Triantafyllias, Konstantinos; Heller, Caroline; de Blasi, Michele et al.
A Sex Difference in HandScan Scores in Rheumatoid Arthritis Patients and Controls? An Ongoing Analysis of the Sex Difference and Other Potential Confounders ReplyJOURNAL OF RHEUMATOLOGY. Bd. 48. H. 6. 2021 S. 951-951
Castven, Darko; Czauderna, Carolin; Becker, Diana et al.
Acquired Resistance to Antiangiogenic Therapies in Hepatocellular Carcinoma Is Mediated by Yes-Associated Protein 1 Activation and Transient Expansion of Stem-Like Cancer CellsHEPATOLOGY COMMUNICATIONS. Bd. 6. H. 5. 2021 S. 1140-1156
Zander, T.; Kelly, R. J.; Ajani, J. A. et al.
Adjuvant nivolumab (NIVO) in resected esophageal or gastroesophageal junction cancer (EC/GEJC) following neoadjuvant chemoradiotherapy (CRT): expanded efficacy and safety analyses from CheckMate 577ONCOLOGY RESEARCH AND TREATMENT. Bd. 44. 2021 S. 80-81
Kelly, Ronan Joseph; Ajani, Jaffer A.; Kuzdzal, Jaroslaw et al.
Adjuvant nivolumab (NIVO) in resected esophageal or gastroesophageal junction cancer (EC/GEJC) following neoadjuvant chemoradiotherapy (CRT): Expanded efficacy and safety analyses from CheckMate 577.JOURNAL OF CLINICAL ONCOLOGY. Bd. 39. H. 15. 2021
Kelly, Ronan J.; Ajani, Jaffer A.; Kuzdzal, Jaroslaw et al.
Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction CancerNEW ENGLAND JOURNAL OF MEDICINE. Bd. 384. H. 13. 2021 S. 1191-1203
Moehler, M.; Ajani, J. A.; Kuzdzal, J. et al.
Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer (EC/GEJC) following neoadjuvant chemoradiotherapy (CRT): 14-month follow-up of CheckMate 577ANNALS OF ONCOLOGY. Bd. 32. 2021 S. S1045-S1046
Kelly, R. J.; Ajani, J.; Kuzdzal, J. et al.
Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer Following Neoadjuvant Chemoradiation Therapy: First Results of the CheckMate 577 StudyANNALS OF SURGICAL ONCOLOGY. Bd. 28. H. SUPPL 1. 2021 S. S41-S42
Hagstrom, Hannes; Adams, Leon A.; Allen, Alina M. et al.
Administrative Coding in Electronic Health Care Record-Based Research of NAFLD: An Expert Panel Consensus StatementHEPATOLOGY. Bd. 74. H. 1. 2021 S. 474-482
Schneider, E.; Lautem, A.; Boedecker, S. C. et al.
AFTER FULL (TWO TIMES) VACCINATION WITH COMIRNATY (R), 28% OF LIVER OR KIDNEY TRANSPLANTED PATIENTS HAD NO T-CELL-REACTIVITY AGAINST SARS-COV-2 SPECIFIC ANTIGENSTRANSPLANT INTERNATIONAL. Bd. 34. 2021 S. 33-34
Woelfinger, Pascal; Hauptrock, Beate; Kriege, Oliver et al.
Alloimmune Myositis as Paraneoplastic Complication of an Oral Squamous Cell Carcinoma After Severe Chronic Graft vs Host Disease or a Manifestation of Chronic Graft vs Host Disease? A Case Report and Literature DiscussionTRANSPLANTATION PROCEEDINGS. Bd. 53. H. 4. 2021 S. 1365-1368
Kreft, Andreas; Hippe, Katrin; Wagner-Drouet, Eva Maria et al.
An investigation of the diagnostic, predictive, and prognostic impacts of three colonic biopsy grading systems for acute graft versus host diseasePLOS ONE. Bd. 16. H. 8. 2021
Zarkovic, M.; Wiersinga, W.; Perros, P. et al.
Antithyroid drugs in Graves' hyperthyroidism: differences between "block and replace" and "titration" regimes in frequency of euthyroidism and Graves' orbitopathy during treatmentJOURNAL OF ENDOCRINOLOGICAL INVESTIGATION. Bd. 44. H. 2. 2021 S. 371-378
Schwaegermann, Marie-Kristin; Schranz, Melanie; Moehler, Markus et al.
Any progress in informed consenting for cancer treatment? Results from a cross sectional analysis at a comprehensive cancer centerJOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. Bd. 147. H. 7. 2021 S. 2117-2126
Kaps, L.; Ahlbrand, C. J.; Gadban, R. et al.
Applicability and safety of discontinuous ADVanced Organ Support (ADVOS) in the treatment of patients with acute-on-chronic liver failure (ACLF) outside of intensive carePLOS ONE. Bd. 16. H. 4. 2021
Munoz-Martinez, Sergio; Sapena, Victor; Forner, Alejandro et al.
Assessing the impact of COVID-19 on liver cancer management (CERO-19)JHEP REPORTS. Bd. 3. H. 3. 2021
Galle, Peter R.; Finn, Richard S.; Cheng, Ann-Lii et al.
Assessment of the impact of anti-drug antibodies on PK and clinical outcomes with atezolizumab plus bevacizumab in HCC.CANCER RESEARCH. Bd. 81. H. 13. 2021
Labenz, Christian; Nagel, Michael; Kaemper, Paula et al.
Association Between Serum Levels of Neurofilament Light Chains and Minimal Hepatic Encephalopathy in Patients With Liver CirrhosisCLINICAL AND TRANSLATIONAL GASTROENTEROLOGY. Bd. 12. H. 10. 2021
Engel, Sinah; Boedecker, Simone; Marczynski, Paul et al.
Association of serum neurofilament light chain levels and neuropsychiatric manifestations in systemic lupus erythematosusTHERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS. Bd. 14. 2021
Moeckel, Tamara; Basta, Fabio; Weinmann-Menke, Julia et al.
B cell activating factor (BAFF): Structure, functions, autoimmunity and clinical implications in Systemic Lupus Erythematosus (SLE)AUTOIMMUNITY REVIEWS. Bd. 20. H. 2. 2021
Furie, Richard; Houssiau, Frederic; Lightstone, Liz et al.
Belimumab Improves Renal Responses in Patients with or Without Steroid Pulses During Induction Therapy for Lupus NephritisARTHRITIS & RHEUMATOLOGY. Bd. 73. 2021 S. 3068-3070
Armandi, Angelo; Schattenberg, Jorn M.
Beyond the Paradigm of Weight Loss in Non-Alcoholic Fatty Liver Disease: From Pathophysiology to Novel Dietary ApproachesNUTRIENTS. Bd. 13. H. 6. 2021
Vali, Yasaman; Lee, Jenny; Schattenberg, Jorn et al.
BIOMARKER SCREENING STRATEGIES TO IDENTIFY FIBROSING STEATOHEPATITIS CASES FOR CLINICAL TRIAL RECRUITMENT IN NAFLDHEPATOLOGY. Bd. 74. 2021 S. 934A-936A
Vali, Yasaman; Lee, Jenny; Schattenberg, Joern M. et al.
Biomarker screening strategies to identify fibrosing steatohepatitis cases for clinical trial recruitment in NAFLDJOURNAL OF HEPATOLOGY. Bd. 75. 2021 S. S568-S569
Gehrke, Nadine; Straub, Beate; Woerns, Marcus-Alexander et al.
Blockade of IL-1 signaling in hepatocytes reduces tumor growth in a mouse model of NAFLD-related HCCJOURNAL OF HEPATOLOGY. Bd. 75. 2021 S. S599-S600
Tilch, Marie-Kristin; Galle, Peter R.; Schattenberg, Joern M. et al.
Burden of depression and anxiety disorders per disease codes in patients with lymphoma in GermanySUPPORTIVE CARE IN CANCER. Bd. 30. H. 3. 2021 S. 2387-2395
Ruiz-Casas, Leonardo; O'Hara, Sonia; Mighiu, Claudia et al.
Burden of illness of progressive familial intrahepatic cholestasis in the US, UK, France, and Germany: study rationale and protocol of the PICTURE studyEXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH. Bd. 21. H. 2. 2021 S. 247-253
Finkelmeier, Fabian; Scheiner, Bernhard; Leyh, Catherine et al.
Cabozantinib in Advanced Hepatocellular Carcinoma: Efficacy and Safety Data from an International Multicenter Real-Life CohortLIVER CANCER. Bd. 10. H. 4. 2021 S. 360-369
Lang, Hauke; Baumgart, Janine; Roth, Wilfried et al.
Cancer gene related characterization of patterns and point of recurrence after resection of colorectal liver metastasesANNALS OF TRANSLATIONAL MEDICINE. Bd. 9. H. 17. 2021
Lazea, Cecilia; Bucerzan, Simona; Al-Khzouz, Camelia et al.
Cardiac Manifestations in a Group of Romanian Patients with Gaucher Disease Type 1 (a Monocentric Study)DIAGNOSTICS. Bd. 11. H. 6. 2021
Schmitt, Volker H.; Leuschner, Anja; Juenger, Claus et al.
Cardiovascular profiling in the diabetic continuum: results from the population-based Gutenberg Health StudyCLINICAL RESEARCH IN CARDIOLOGY. Bd. 111. H. 3. 2021 S. 272-283
Van Cutsem, Eric; Singh, Prianka; Cleary, James M. et al.
Checkmate 577:Health-related quality of life (HRQoL) in a randomized, double-blind phase III study of nivolumab (NIVO) versus placebo (PBO) as adjuvant treatment in patients (pts) with resected esophageal or gastroesophageal junction cancer (EC/GEJC).JOURNAL OF CLINICAL ONCOLOGY. Bd. 39. H. 3. 2021
Schellhaas, Barbara; Bernatik, Thomas; Bohle, Wolfram et al.
Christiane Wiegard, IsabelWiesinger, UweWill, Matthias Ziesch, Patrick Zimmermann, Deike Strobel. Contrast-Enhanced Ultrasound Algorithms (CEUS-LIRADS/ESCULAP) for the Noninvasive Diagnosis of Hepatocellular Carcinoma - A Prospective Multicenter DEGUM Study (vol 42, pg 178, 2021)ULTRASCHALL IN DER MEDIZIN. Bd. 42. H. 02. 2021 S. 186-186
Ruiz-Casas, Leonardo; Pedra, Gabriel; Shaikh, Anum et al.
Clinical and sociodemographic determinants of disease progression in patients with nonalcoholic steatohepatitis in the United StatesMEDICINE. Bd. 100. H. 50. 2021
Haupts, Anna; Vogel, Anne; Foersch, Sebastian et al.
Comparative analysis of nuclear and mitochondrial DNA from tissue and liquid biopsies of colorectal cancer patientsSCIENTIFIC REPORTS. Bd. 11. H. 1. 2021
Vali, Yasaman; Lee, Jenny; Schattenberg, Joern et al.
Comparative diagnostic accuracy of blood-based biomarkers for diagnosing NASH: phase 1 results of the LITMUS projectJOURNAL OF HEPATOLOGY. Bd. 75. 2021 S. S564-S565
Lee, Jenny; Vali, Yasaman; Boursier, Jerome et al.
COMPARATIVE DIAGNOSTIC ACCURACY OF BLOOD-BASED BIOMARKERS FOR STAGING FIBROSIS IN NAFLD: PHASE 1 RESULTS OF THE LITMUS PROJECTHEPATOLOGY. Bd. 74. 2021 S. 939A-940A
Lee, Jenny; Vali, Yasaman; Boursier, Jerome et al.
Comparative diagnostic accuracy of blood-based biomarkers for staging fibrosis in NAFLD: phase 1 results of the LITMUS projectJOURNAL OF HEPATOLOGY. Bd. 75. 2021 S. S255-S256
Vali, Yasaman; Lee, Jenny; Schattenberg, Jorn et al.
COMPARATIVE DIAGNOSTIC ACCURACY OF BLOOD-BASED BIOMARKERS IN DETECTING NASH: PHASE 1 RESULTS OF THE LITMUS PROJECTHEPATOLOGY. Bd. 74. 2021 S. 940A-942A
Ridder, Dirk Andreas; Weinmann, Arndt; Schindeldecker, Mario et al.
Comprehensive clinicopathologic study of alpha fetoprotein-expression in a large cohort of patients with hepatocellular carcinomaINTERNATIONAL JOURNAL OF CANCER. Bd. 150. H. 6. 2021 S. 1053-1066
Schellhaas, Barbara; Bernatik, Thomas; Bohle, Wolfram et al.
Contrast-Enhanced Ultrasound Algorithms (CEUS-LIRADS/ESCULAP) for the Noninvasive Diagnosis of Hepatocellular Carcinoma - A Prospective Multicenter DEGUM StudyULTRASCHALL IN DER MEDIZIN. Bd. 42. H. 02. 2021 S. 178-186
Schellhaas, Barbara; Bernatik, Thomas; Bohle, Wolfram et al.
Contrast-Enhanced Ultrasound Algorithms (CEUS-LIRADS/ESCULAP) for the Noninvasive Diagnosis of Hepatocellular Carcinoma - A Prospective Multicenter DEGUM Study (vol 42, pg 178, 2021)ULTRASCHALL IN DER MEDIZIN. Bd. 42. H. 02. 2021 S. E20-E20
Sprinzl, Martin F.; Feist, Christina; Koch, Sandra et al.
Cost evaluation of PAGE-B risk score guided HCC surveillance in patients with treated chronic hepatitis BBMC HEALTH SERVICES RESEARCH. Bd. 21. H. 1. 2021
Schwaegermann, Marie-Kristin; Hobohm, Lukas; Rausch, Johanna et al.
COVID-19 as a Potential Trigger for Immune Thrombotic Thrombocytopenic Purpura and Reason for an Unusual Treatment: A Case ReportHAMOSTASEOLOGIE. 2021
Boedecker, Simone C.; Klimpke, Pascal; Kraus, Daniel et al.
COVID-19-Importance for Patients on the Waiting List and after Kidney Transplantation-A Single Center Evaluation in 2020-2021PATHOGENS. Bd. 10. H. 4. 2021
Boegel, Sebastian; Castle, John C.; Schwarting, Andreas
Current status of use of high throughput nucleotide sequencing in rheumatologyRMD OPEN. Bd. 7. H. 1. 2021
Mueller, Lukas; Stoehr, Fabian; Maehringer-Kunz, Aline et al.
Current Strategies to Identify Patients That Will Benefit from TACE Treatment and Future Directions a Practical Step-by-Step GuideJOURNAL OF HEPATOCELLULAR CARCINOMA. Bd. 8. 2021 S. 403-419
Maderer, Annett; Fiteni, Frederic; Tanis, Erik et al.
CXCR4 and hif-1 alpha as prognostic molecular markers for stage 3 colon cancer patients: post hoc analysis of the randomized, multicenter phase 3 PETACC-2 trial datasetACTA ONCOLOGICA. Bd. 60. H. 11. 2021 S. 1543-1547
Pitton, Michael B.; Zimmermann, Tim; Mildenberger, Philipp et al.
Decision making for transjugular intrahepatic portosystemic stent shunt in refractory ascites and variceal bleeding: MELD, or not MELD, that is the questionEUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY. Bd. 33. 2021 S. E214-E222
Galle, Peter R.; Abou-Alfa, Ghassan K.
Decision making in systemic therapy of hepatocellular carcinoma: Should we pay attention to disease aetiology?JOURNAL OF HEPATOLOGY. Bd. 75. H. 4. 2021 S. 763-764
Wedemeyer, Heiner; Herzer, Kerstin; Serfert, Yvonne et al.
Declining Numbers of Hepatitis C Virus-Associated Liver Transplantations in GermanyDEUTSCHES ARZTEBLATT INTERNATIONAL. Bd. 118. H. 46. 2021 S. 797-798